Benzinga | May 5, 2021 04:13PM EDT

Supernus Pharmaceuticals Q1 EPS $0.11 Misses $0.24 Estimate, Sales $130.90M Beat $129.20M Estimate

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.24 by 54.17 percent. This is a 72.5 percent decrease over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $130.90 million which beat the analyst consensus estimate of $129.20 million by 1.32 percent. This is a 37.82 percent increase over sales of $94.98 million the same period last year.